能特科技(002102) - 2024 Q4 - 年度业绩

Financial Performance - The company achieved total operating revenue of 1,228,043.87 million yuan in 2024, representing a year-on-year increase of 10.35%[5] - The net profit attributable to shareholders was -48,893.86 million yuan, a decline of 288.97% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -41,651.47 million yuan, a significant drop of 10,112.05% year-on-year[5] - The company reported a total asset value of 840,016.61 million yuan at the end of the reporting period, down 8.19% from the beginning of the period[4] - The equity attributable to shareholders decreased by 11.96% to 360,080.84 million yuan[4] - There were no discrepancies between the reported performance and the previously disclosed earnings forecast[6] Business Strategy - The company plans to optimize its e-commerce business structure and reduce the scale of operations, including shutting down high-cost, low-profit subsidiaries[5] - The company intends to focus on its core business in fine chemicals and enhance research and development of new products and technologies[5] - The company will concentrate resources to strengthen its pharmaceutical, pharmaceutical intermediates, and vitamin sectors[5] Investment Properties - The fair value of investment properties decreased by 11,528.66 million yuan due to a high vacancy rate resulting from tenant clean-up efforts[5]